Navigation Links
Study finds higher risk for celiac disease in some children
Date:7/3/2014

AURORA, Colo. (July 3, 2014) Physicians from the University of Colorado School of Medicine in collaboration with an international team of researchers have demonstrated that screening of genetically susceptible infants can lead to the diagnosis of celiac disease at a very early age.

The collaborative group studied 6,403 children with specific genetic markers from birth to identify the factors involved in the development of both celiac disease and type 1 diabetes. The children are from the United States, Finland, Germany and Sweden and are part of The Environmental Determinants of Diabetes in the Young (TEDDY) study. Interestingly, the study also found that Swedish residents had a higher risk for celiac disease than their European neighbors in Finland and Germany, and a nearly two-fold higher risk of celiac disease than their U.S. counterparts, despite sharing the same high-risk celiac genes.

Celiac disease is an autoimmune disease that damages the small intestine and interferes with absorption of nutrients from food. It can sometimes develop silently, leading to long-term medical complications if left untreated. People who have celiac disease cannot tolerate gluten, a protein in wheat, rye, and barley. Gluten is found mainly in foods but may also be found in everyday products such as medicines, vitamins, and lip balms.

The study is published in the July 3 issue of The New England Journal of Medicine. The research was funded by the NIH, the Juvenile Diabetes Research Foundation and Centers for Disease Control and Prevention.

Edwin Liu, MD, associate professor of pediatrics at the University of Colorado School of Medicine and lead author of the study, said the findings are significant because it will help determine when screening should begin in at-risk children. In addition, it will allow the group to explore factors that may be causing Swedish children to develop celiac disease at a higher rate than other countries.

"The findings in this report set the stage for the study of complex relationships between genetic, environmental and gestational factors that may play a role in the development of celiac disease in early childhood," said Liu, who is the Taplin Endowed Chair for Celiac Disease and director of the Colorado Center for Celiac Disease at Children's Hospital Colorado.

Marian Rewers, MD, PhD, the principal investigator of TEDDY, and the late George Eisenbarth, MD, PhD, both from the Barbara Davis Center for Childhood Diabetes, are co-authors of the study. The senior author and leader of the Celiac Disease Committee within TEDDY is Daniel Agardh, MD, PhD, from Lund University in Sweden. Other contributors to the study are from the University of South Florida, the Pacific Northwest Diabetes Research Institute in Seattle, Ludwig-Maximilians-University in Germany, the University of Bristol in the United Kingdom, Dresden University in Germany, the University of Turku in Finland and members of the TEDDY Study Group.

The primary goal of TEDDY is to find the causes of type 1 diabetes and celiac disease. TEDDY has screened more than 425,000 infants who are at high risk for type 1 diabetes, eventually following the health of 8,677 children among more than 20,000 eligible to participate. Because the major genetic factors that confer risk for type 1 diabetes are shared by celiac disease, researchers are evaluating this group for development of celiac disease.


'/>"/>

Contact: Mark Couch
mark.couch@ucdenver.edu
303-724-5377
University of Colorado Denver
Source:Eurekalert

Related medicine news :

1. New study will discover why women freeze their eggs
2. New study discovers biological basis for magic mushroom mind expansion
3. Twin study links community socioeconomic deprivation to sleep duration
4. GW researcher receives more than $1 million in grants to study epigenetics of pancreatic cancer
5. Study finds online bullying creates off-line fear at school
6. Drink walkers do it because their mates think its okay: QUT study
7. First pediatric autism study conducted entirely online
8. New research study shows huge savings for health care
9. Study: Four Habits Model prepares pediatric nurses for emotionally difficult discussions
10. New study from population and development review finds flaws in mortality projections
11. Study finds low hand hygiene compliance rates during anesthesia administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology: